Search

Your search keyword '"A. De Maio"' showing total 265 results
Start Over Author "A. De Maio" Publisher elsevier b.v.
265 results on '"A. De Maio"'

1. Staphylococcus aureus colonizing the skin microbiota of adults with severe atopic dermatitis exhibits genomic diversity and convergence in biofilm traits

Author

Sivori, Francesca, Cavallo, Ilaria, Truglio, Mauro, De Maio, Flavio, Sanguinetti, Maurizio, Fabrizio, Giorgia, Licursi, Valerio, Francalancia, Massimo, Fraticelli, Fulvia, La Greca, Ilenia, Lucantoni, Federica, Camera, Emanuela, Mariano, Maria, Ascenzioni, Fiorentina, Cristaudo, Antonio, Pimpinelli, Fulvia, and Di Domenico, Enea Gino

Published
2024
Full Text
View/download PDF

20. Characterization of gut microbiota in patients with metabolic syndrome candidates for bariatric/metabolic surgery: Preliminary findings of a multi-center prospective study

Author

De Maio, Flavio, Boru, Cristian Eugeniu, Avallone, Marcello, Velotti, Nunzio, Bianco, Delia Mercedes, Capoccia, Danila, Greco, Francesco, Guarisco, Gloria, Nogara, Manuela, Sanguinetti, Maurizio, Verrastro, Ornella, Capaldo, Brunella, Musella, Mario, Raffaelli, Marco, Delogu, Giovanni, Silecchia, Gianfranco, and Leonetti, Frida

Published
2021
Full Text
View/download PDF

24. New insights on human Hsp70-escort protein 1: Chaperone activity, interaction with liposomes, cellular localizations and HSPA's self-assemblies remodeling

Author

Dores-Silva, Paulo Roberto, Kiraly, Vanessa Thomaz Rodrigues, Moritz, Milene Nóbrega de Oliveira, Serrão, Vitor Hugo Balasco, dos Passos, Patrícia Maria Siqueira, Spagnol, Valentine, Teixeira, Felipe Roberti, Gava, Lisandra Marques, Cauvi, David Mario, Ramos, Carlos Henrique Inácio, De Maio, Antonio, and Borges, Júlio César

Published
2021
Full Text
View/download PDF

41. Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients

Author

Del Zompo, F., De Maio, Flavio, Santopaolo, Francesco, Ricci, Riccardo, Gasbarrini, Antonio, Pompili, Maurizio, Ponziani, Francesca Romana, De Maio F., Santopaolo F., Ricci R. (ORCID:0000-0002-9089-5084), Gasbarrini A. (ORCID:0000-0002-7278-4823), Pompili M. (ORCID:0000-0001-6699-7980), Ponziani F. R. (ORCID:0000-0002-5924-6238), Del Zompo, F., De Maio, Flavio, Santopaolo, Francesco, Ricci, Riccardo, Gasbarrini, Antonio, Pompili, Maurizio, Ponziani, Francesca Romana, De Maio F., Santopaolo F., Ricci R. (ORCID:0000-0002-9089-5084), Gasbarrini A. (ORCID:0000-0002-7278-4823), Pompili M. (ORCID:0000-0001-6699-7980), and Ponziani F. R. (ORCID:0000-0002-5924-6238)

Abstract

N/A

Published
2021

42. Re-evaluating positive serum samples for SARS-CoV-2-specific IgA and IgG antibodies using an in-house serological assay

Author

Cacaci, Margherita, Menchinelli, Giulia, Ricci, Rosalba, De Maio, Flavio, Mariotti, Melinda, Torelli, Riccardo, Morandotti, Grazia Angela, Bugli, Francesca, Sanguinetti, Maurizio, Posteraro, Brunella, Cacaci M. (ORCID:0000-0002-5433-9400), Menchinelli G., Ricci R., De Maio F., Mariotti M., Torelli R., Morandotti G. A., Bugli F. (ORCID:0000-0001-9038-3233), Sanguinetti M. (ORCID:0000-0002-9780-7059), Posteraro B. (ORCID:0000-0002-1663-7546), Cacaci, Margherita, Menchinelli, Giulia, Ricci, Rosalba, De Maio, Flavio, Mariotti, Melinda, Torelli, Riccardo, Morandotti, Grazia Angela, Bugli, Francesca, Sanguinetti, Maurizio, Posteraro, Brunella, Cacaci M. (ORCID:0000-0002-5433-9400), Menchinelli G., Ricci R., De Maio F., Mariotti M., Torelli R., Morandotti G. A., Bugli F. (ORCID:0000-0001-9038-3233), Sanguinetti M. (ORCID:0000-0002-9780-7059), and Posteraro B. (ORCID:0000-0002-1663-7546)

Abstract

Not available

Published
2021

43. Erratum to 'Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes' [The Breast (2023) 102–109].

Author

Glemarec, Gauthier, Lacaze, Jean-Louis, Cabarrou, Bastien, Aziza, Richard, Jouve, Eva, Zerdoud, Slimane, De Maio, Eleonora, Massabeau, Carole, Loo, Maxime, Esteyrie, Vincent, Ung, Mony, Dalenc, Florence, Izar, Francoise, and Chira, Ciprian

Subjects
HEALTH outcome assessment, BREAST cancer
Published
2023
Full Text
View/download PDF

48. Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes.

Author

Glemarec, Gauthier, Lacaze, Jean-Louis, Cabarrou, Bastien, Aziza, Richard, Jouve, Eva, Zerdoud, Slimane, De Maio, Eleonora, Massabeau, Carole, Loo, Maxime, Esteyrie, Vincent, Ung, Mony, Dalenc, Florence, Izar, Francoise, and Chira, Ciprian

Subjects
HEALTH outcome assessment, STEREOTACTIC radiotherapy, VOLUMETRIC-modulated arc therapy, BREAST cancer, PROGNOSIS, COLD therapy
Abstract

Local ablative treatment (LAT) is increasingly combined with systemic therapy in oligometastatic breast cancer (OMBC), without a high-level evidence to support this strategy. We evaluated the addition of LAT to systemic treatment in terms of progression-free survival (PFS) and overall survival (OS). Secondary endpoints were local control (LC) and toxicity. We sought to identify prognostic factors associated with longer OS and PFS. We identified consecutive patients treated between 2014 and 2018 for synchronous or metachronous OMBC (defined as ≤ 5 metastases). LAT included stereotactic body radiation therapy (SBRT) and volumetric modulated arc therapy (VMAT), surgery, cryotherapy and percutaneous radiofrequency ablation (PRA). PFS and OS were calculated, and Cox regression models analyzed for potential predictors of survival. One hundred two patients were included (no-LAT, n = 62; LAT, n = 40). Sixty-four metastases received LAT. Median follow-up was 50.4 months (95% CI [44.4; 53.4]). One patient experienced grade 3 toxicity in the LAT group. Five-year PFS and OS were 34.75% (95% CI [24.42–45.26]) and 63.21% (95% CI [50.69–73.37]) respectively. Patients receiving both LAT and systemic therapy had longer PFS and OS than those with no-LAT ([HR 0.39, p = 0.002]) and ([HR 0.31, p = 0.01]). The use of LAT, HER2-positive status and hormone-receptor positivity were associated with longer PFS and OS whereas liver metastases led to worse PFS. LAT was associated with improved outcomes in OMBC when added to systemic treatment, without significantly increasing toxicity. The prognostic factors identified to extend PFS and OS may help guide clinicians in selecting patients for LAT. • Outcomes of oligometastatic breast cancer (OMBC) cohort without cranial metastatases treated by local ablative treatment and systemic treatment. • Patients with LAT had more favorable PFS and OS compared to noLAT. • HR+ and HER + immunohistochemical (HIC) subtype had a more favorable OS and PFS compared to triple negatives patients, liver metastases had a worse PFS. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

49. Unilateral genu valgum associated to vitamin D deficiency: A multidisciplinary approach in a patient followed from 3 to 21 years - A case report.

Author

Salera, S., Luciano, C., De Luna, V., Rovere, G., De Maio, F., and Farsetti, P.

Abstract

Lower limb postural deformities are usually bilateral and in the majority of cases tend to spontaneous correction without any treatment. On the contrary, unilateral genu valgum is a rare deformity in children, it is frequently associated with systemic pathological conditions and require a specific treatment. A three-year-old child affected by severe unilateral left genu valgum was followed by a multidisciplinary team. The initial treatment was medical, based on 10,000 IU of cholecalciferol every 2 months without any improvement after 6 months. Therefore, the patient was surgically treated by hemiepiphysiodesis of distal femur and proximal tibia with eight-plate obtaining a complete correction of the deformity in 10 months. Medical treatment continued for 4 years since the diagnosis. At follow-up, 18 years later, an excellent clinical result was observed. The association between unilateral genu valgum and vitamin D deficiency is extremely rare. In case of unilateral limb deformity, it is essential to investigate the aetiology to obtain a correct diagnosis and perform a specific multidisciplinary treatment. The goal of the management is to correct the deformity and avoid any recurrence. We believe that in unilateral genu valgum is always necessary a correct multidisciplinary diagnosis and treatment. The peculiarity of our case is the long-term follow-up and the absence of recurrence despite early surgical treatment. Further studies are necessary to better define the correlation between unilateral axial deformity and vitamin D deficiency. • Unilateral genu valgum is a rare deformity in children frequently associated with systemic pathological conditions. • There is no evidence in the literature of a specific association between unilateral genu valgum and hypovitaminosis D. • To achieve adequate correction of unilateral genu valgum , a multidisciplinary approach is necessary. • Medical therapy associated with hemiepiphysiodesis using eight-plate allowed to obtain excellent long-term results. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results